- US-listed companies
- Blueprint Medicines Corp
- Balance sheet
Blueprint Medicines Corp【BPMC】Balance sheet
Market cap
$8.4B
P/E ratio
| 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | |
| Cash and cash equivalents | 163 | 52 | 400 | 73 | 120 | 690 | 215 | 125 | 82 | 114 |
| Marketable securities, current | - | 162 | 273 | 426 | 370 | 187 | 267 | 825 | 639 | 513 |
| Total cash & short-term investments | 163 | 214 | 673 | 499 | 489 | 877 | 482 | 950 | 721 | 627 |
| Accounts receivable, net | - | - | - | - | 1 | 7 | 25 | 24 | 43 | 76 |
| Inventories | - | - | - | - | - | 9 | 22 | 30 | 21 | 14 |
| Total current assets | 170 | 220 | 686 | 500 | 517 | 928 | 554 | 1,047 | 808 | 743 |
| Property, plant and equipment, net | 7 | 6 | 24 | 30 | 38 | 34 | 31 | 33 | 42 | 37 |
| Marketable securities, non-current | - | 54 | - | - | 64 | 678 | 558 | 133 | 57 | 248 |
| Total non-current assets | 8 | 62 | 30 | 40 | 191 | 791 | 698 | 303 | 241 | 437 |
| Total assets | 179 | 283 | 716 | 540 | 708 | 1,718 | 1,252 | 1,350 | 1,049 | 1,180 |
| Accounts payable | 2 | 2 | 4 | 3 | 5 | 4 | 8 | 3 | 5 | 7 |
| Total current liabilities | 19 | 29 | 43 | 60 | 106 | 131 | 150 | 183 | 215 | 261 |
| Total non-current liabilities | - | - | - | 61 | 137 | 118 | 132 | 652 | 704 | 620 |
| Total liabilities | - | - | - | 121 | 243 | 248 | 281 | 835 | 919 | 881 |
| Common stock and paid-in capital | 279 | 421 | 980 | 1,017 | 1,412 | 2,107 | 2,250 | 2,358 | 2,474 | 2,709 |
| Retained earnings | -135 | -207 | -356 | -598 | -945 | -631 | -1,275 | -1,833 | -2,340 | -2,407 |
| Stockholders' equity | 144 | 213 | 624 | 419 | 464 | 1,470 | 971 | 515 | 131 | 299 |
| Working capital | - | - | - | - | - |